Diabetes, hypertension and dyslipidemia medication prescribing in Qatari primary care settings: a retrospective analysis of electronic medical records

Background Globally, non-communicable diseases (NCDs) are recognised as a leading cause of morbidity and mortality. Medications and medicines optimisation play an important role in the management of modifiable physiological risk factors and NCDs. The importance of lifestyle interventions in preventi...

Full description

Bibliographic Details
Main Authors: Mohamed Ahmed Syed, Ahmed Sameer Al Nuaimi, Hamda Abdulla A/Qotba, Abduljaleel Abdullatif Zainel, Tamara Marji, Uzma Razaq
Format: Article
Language:English
Published: Taylor & Francis Group 2021-12-01
Series:Journal of Pharmaceutical Policy and Practice
Subjects:
Online Access:http://dx.doi.org/10.1186/s40545-021-00353-4
_version_ 1827593218900885504
author Mohamed Ahmed Syed
Ahmed Sameer Al Nuaimi
Hamda Abdulla A/Qotba
Abduljaleel Abdullatif Zainel
Tamara Marji
Uzma Razaq
author_facet Mohamed Ahmed Syed
Ahmed Sameer Al Nuaimi
Hamda Abdulla A/Qotba
Abduljaleel Abdullatif Zainel
Tamara Marji
Uzma Razaq
author_sort Mohamed Ahmed Syed
collection DOAJ
description Background Globally, non-communicable diseases (NCDs) are recognised as a leading cause of morbidity and mortality. Medications and medicines optimisation play an important role in the management of modifiable physiological risk factors and NCDs. The importance of lifestyle interventions in prevention of modifiable risk factors is also well established. The aim of this paper was to describe the quantity of type 2 diabetes mellitus (T2DM), hypertension and dyslipidaemia prescribing in Qatari primary care settings. Its findings will provide necessary information to inform pharmaceutical policy and practice. Methods The study was undertaken in Qatar’s publicly funded primary health care centres. Data sources for this study comprised electronic medical records. The Anatomical Therapeutic Chemical (ATC) drug classification system was used to classify the medications prescribed. The number and proportion of medications by age, sex, nationality and diagnosis (T2DM, hypertension and dyslipidaemia) were reported. Results A total 81,569 individuals were included (18–29 years 2.4%; 30–39 years 11.7%; 40–49 years 25.4%; 50–59 years 31.9% and ≥ 60 years 28.6%). 55.6% participants were male. On average 10.2 medications were prescribed per person and 2.3 medications were included in each prescription. T2DM medications were most prescribed (N = 361,87780,799; 43.2%) followed by hypertension (N = 303,086; 36.2%) and dyslipidaemia (N = 172,163; 20.5%). Of the total medications prescribed, 72% (N = 605,488) were prescribed in individuals aged 50 years and above. Men were prescribed 62% (N = 515,043) medications while women were prescribed 38% (N = 322,083) medications. Southern Asians (N = 330,338; 39%) were prescribed most medication followed by Qataris (N = 181,328; 22%) and Northern African (N = 145,577; 17%). Conclusions In Qatar’s primary care settings, average medications prescribed per patients were found to be higher compared to other populations. While medications were actively prescribed for the 3 conditions, the study found variations by medication type, age, gender and nationality. Rational guidelines for the utilisation of medications need to be established with the support of real-world evidence.
first_indexed 2024-03-09T02:07:17Z
format Article
id doaj.art-0bd285b5b0de481d9a07af1e19638222
institution Directory Open Access Journal
issn 2052-3211
language English
last_indexed 2024-03-09T02:07:17Z
publishDate 2021-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Pharmaceutical Policy and Practice
spelling doaj.art-0bd285b5b0de481d9a07af1e196382222023-12-07T15:28:03ZengTaylor & Francis GroupJournal of Pharmaceutical Policy and Practice2052-32112021-12-0114110.1186/s40545-021-00353-412315267Diabetes, hypertension and dyslipidemia medication prescribing in Qatari primary care settings: a retrospective analysis of electronic medical recordsMohamed Ahmed Syed0Ahmed Sameer Al Nuaimi1Hamda Abdulla A/Qotba2Abduljaleel Abdullatif Zainel3Tamara Marji4Uzma Razaq5Directorate of Clinical Affairs,Directorate of Clinical Affairs,Directorate of Clinical Affairs,Directorate of Clinical Affairs,Directorate of Clinical Affairs,Directorate of Clinical Operations,Background Globally, non-communicable diseases (NCDs) are recognised as a leading cause of morbidity and mortality. Medications and medicines optimisation play an important role in the management of modifiable physiological risk factors and NCDs. The importance of lifestyle interventions in prevention of modifiable risk factors is also well established. The aim of this paper was to describe the quantity of type 2 diabetes mellitus (T2DM), hypertension and dyslipidaemia prescribing in Qatari primary care settings. Its findings will provide necessary information to inform pharmaceutical policy and practice. Methods The study was undertaken in Qatar’s publicly funded primary health care centres. Data sources for this study comprised electronic medical records. The Anatomical Therapeutic Chemical (ATC) drug classification system was used to classify the medications prescribed. The number and proportion of medications by age, sex, nationality and diagnosis (T2DM, hypertension and dyslipidaemia) were reported. Results A total 81,569 individuals were included (18–29 years 2.4%; 30–39 years 11.7%; 40–49 years 25.4%; 50–59 years 31.9% and ≥ 60 years 28.6%). 55.6% participants were male. On average 10.2 medications were prescribed per person and 2.3 medications were included in each prescription. T2DM medications were most prescribed (N = 361,87780,799; 43.2%) followed by hypertension (N = 303,086; 36.2%) and dyslipidaemia (N = 172,163; 20.5%). Of the total medications prescribed, 72% (N = 605,488) were prescribed in individuals aged 50 years and above. Men were prescribed 62% (N = 515,043) medications while women were prescribed 38% (N = 322,083) medications. Southern Asians (N = 330,338; 39%) were prescribed most medication followed by Qataris (N = 181,328; 22%) and Northern African (N = 145,577; 17%). Conclusions In Qatar’s primary care settings, average medications prescribed per patients were found to be higher compared to other populations. While medications were actively prescribed for the 3 conditions, the study found variations by medication type, age, gender and nationality. Rational guidelines for the utilisation of medications need to be established with the support of real-world evidence.http://dx.doi.org/10.1186/s40545-021-00353-4primary health carediabeteshypertensiondyslipidaemiaprescriptionsqatar
spellingShingle Mohamed Ahmed Syed
Ahmed Sameer Al Nuaimi
Hamda Abdulla A/Qotba
Abduljaleel Abdullatif Zainel
Tamara Marji
Uzma Razaq
Diabetes, hypertension and dyslipidemia medication prescribing in Qatari primary care settings: a retrospective analysis of electronic medical records
Journal of Pharmaceutical Policy and Practice
primary health care
diabetes
hypertension
dyslipidaemia
prescriptions
qatar
title Diabetes, hypertension and dyslipidemia medication prescribing in Qatari primary care settings: a retrospective analysis of electronic medical records
title_full Diabetes, hypertension and dyslipidemia medication prescribing in Qatari primary care settings: a retrospective analysis of electronic medical records
title_fullStr Diabetes, hypertension and dyslipidemia medication prescribing in Qatari primary care settings: a retrospective analysis of electronic medical records
title_full_unstemmed Diabetes, hypertension and dyslipidemia medication prescribing in Qatari primary care settings: a retrospective analysis of electronic medical records
title_short Diabetes, hypertension and dyslipidemia medication prescribing in Qatari primary care settings: a retrospective analysis of electronic medical records
title_sort diabetes hypertension and dyslipidemia medication prescribing in qatari primary care settings a retrospective analysis of electronic medical records
topic primary health care
diabetes
hypertension
dyslipidaemia
prescriptions
qatar
url http://dx.doi.org/10.1186/s40545-021-00353-4
work_keys_str_mv AT mohamedahmedsyed diabeteshypertensionanddyslipidemiamedicationprescribinginqatariprimarycaresettingsaretrospectiveanalysisofelectronicmedicalrecords
AT ahmedsameeralnuaimi diabeteshypertensionanddyslipidemiamedicationprescribinginqatariprimarycaresettingsaretrospectiveanalysisofelectronicmedicalrecords
AT hamdaabdullaaqotba diabeteshypertensionanddyslipidemiamedicationprescribinginqatariprimarycaresettingsaretrospectiveanalysisofelectronicmedicalrecords
AT abduljaleelabdullatifzainel diabeteshypertensionanddyslipidemiamedicationprescribinginqatariprimarycaresettingsaretrospectiveanalysisofelectronicmedicalrecords
AT tamaramarji diabeteshypertensionanddyslipidemiamedicationprescribinginqatariprimarycaresettingsaretrospectiveanalysisofelectronicmedicalrecords
AT uzmarazaq diabeteshypertensionanddyslipidemiamedicationprescribinginqatariprimarycaresettingsaretrospectiveanalysisofelectronicmedicalrecords